Amneal Pharmaceuticals receives FDA approval for albuterol inhalation aerosol.

Amneal Pharmaceuticals has received FDA approval for its albuterol sulfate inhalation aerosol, a generic equivalent of PROAIR HFA. This follows the approval of its beclomethasone dipropionate inhalation aerosol, a generic equivalent of QVAR. The approvals demonstrate Amneal's momentum in building a high-value respiratory portfolio supported by its state-of-the-art manufacturing platform.